Corbus Pharmaceuticals Holdings, Inc. Share Price

Corbus Pharmaceuticals Holdings, Inc. Share Price

NASDAQ: CRBP | Micro Cap
$4.23
-$0.01 (-0.35%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Corbus Pharmaceuticals Holdings, Inc. Stock Performance

Open
$4.29
Prev. Close
$4.25
Circuit Range
N/A
Day Range
$4.10 - $4.32
Year Range
$3.88 - $17.69
Volume
26,945
Average Traded
$4.19

Corbus Pharmaceuticals Holdings, Inc. Share Price Today

As of 30 October 2026, Corbus Pharmaceuticals Holdings, Inc.'s share price is $4.23. The stock opened at $4.29, compared to its previous close of $4.25. During today's trading session, Corbus Pharmaceuticals Holdings, Inc.'s share price traded between $4.10 and $4.32, with an average price of $4.21. Over the past 52 weeks, the stock has recorded a high of $17.69 and a low of $3.88. In terms of performance, Corbus Pharmaceuticals Holdings, Inc.'s share price has declined by 57.32% over the last six months and is down 65.01% on a year-on-year basis.

Corbus Pharmaceuticals Holdings, Inc. Share Price Chart

Line chart of the Corbus Pharmaceuticals Holdings, Inc. price trend over the selected period. The price fell overall, ranging from 4.10 to 4.32, ending at 4.23.
$4.10$4.32
L
Show Current Price
H

Corbus Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$56.33M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-99.67%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-50.13%

Corbus Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$23.34-$20.56-$22.97-$35.04
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A11.91%-11.72%-52.55%

Corbus Pharmaceuticals Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.35-$44.60-$40.21-$78.54
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.31%9.84%-95.32%

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Corbus Pharmaceuticals Holdings, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$6.76
$4.22
-37.99%
Sep 2026
$10.66
$6.80
-38.91%
Aug 2026
$8.86
$11.14
+23.92%
Jul 2026
$9.30
$8.99
-4.31%
Jun 2026
$7.74
$9.39
+19.15%
May 2026
$9.70
$7.88
-20.43%
Apr 2026
$10.11
$9.91
+5.65%
Mar 2026
$8.39
$9.38
+10.09%
Feb 2026
$8.33
$8.52
+3.21%
Jan 2026
$8.19
$8.26
+1.68%
Dec 2025
$11.27
$8.12
-29.18%
Nov 2025
$12.28
$11.46
-5.17%

CRBP Share Price FAQs